Combinent Biomedical Systems, a women's healthcare company, has been empowering women's health since their establishment in 2000. They are known for their advanced multi-segmented vaginal rings designed for the targeted delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. The company focuses on transvaginal delivery of medications for women's reproductive endocrinology disorders, diabetes, obesity, and infectious diseases. Headquartered in Lexington, Massachusetts, Combinent Biomedical Systems received a significant $600.00K Venture Round investment on 02 October 2012. This innovative startup operates in the Biotechnology, Health Care, and Women's Health industries, offering promising potential for both investors and the improvement of women's healthcare.
Combinent Biomedical Systems
Empowering women's health with advanced multi-segmented vaginal rings for targeted therapeutic delivery.
General Information
Get notified when Combinent Biomedical Systems moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Combinent Biomedical Systems
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Combinent Biomedical Systems
Taxonomy: women's health, vaginal rings, therapeutic delivery, reproductive endocrinology, drug delivery, biomedical systems, transvaginal delivery, medications, hydrophobic molecules, hydrophilic molecules, proteins, large molecules, diabetes treatment, obesity treatment, infectious diseases
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 02 Oct 2012 | |
| Debt Financing | •••••• | - | 04 Jan 2012 | |
| Venture Round | •••••• | - | 29 Dec 2010 | |
| Debt Financing | •••••• | - | 29 Sep 2010 | |
| Venture Round | •••••• | 3 |
|
17 Dec 2009 |
Combinent Biomedical Systems Alternatives & Competitors
Revolutionizing targeted gastrointestinal treatments
Alma Therapeutics is developing a disruptive capsule for oral delivery of complex and biologic molec...
FAQ About Combinent Biomedical Systems
Don't just browse. Track.
Signal Tracker monitors Combinent Biomedical Systems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.